Ardent Health (NYSE:ARDT) Given New $15.00 Price Target at Guggenheim

Ardent Health (NYSE:ARDT) had its target price cut by stock analysts at Guggenheim from $18.00 to $15.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Guggenheim’s target price would suggest a potential upside of 80.61% from the company’s current price.

A number of other research analysts have also weighed in on ARDT. The Goldman Sachs Group initiated coverage on Ardent Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $19.00 price objective for the company. Morgan Stanley reissued an “equal weight” rating and issued a $12.00 target price (down from $22.00) on shares of Ardent Health in a report on Friday. Weiss Ratings raised shares of Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. KeyCorp cut shares of Ardent Health from an “overweight” rating to a “sector weight” rating in a research note on Monday. Finally, JPMorgan Chase & Co. cut their price objective on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating on the stock in a research report on Monday, August 11th. Six research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $15.67.

Ardent Health Trading Down 7.8%

Shares of Ardent Health stock opened at $8.31 on Tuesday. Ardent Health has a 1-year low of $8.28 and a 1-year high of $17.34. The company’s fifty day simple moving average is $13.70 and its 200-day simple moving average is $13.32. The stock has a market capitalization of $1.19 billion, a PE ratio of 5.73, a P/E/G ratio of 5.03 and a beta of 0.44. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 2.00.

Ardent Health (NYSE:ARDT) last released its earnings results on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.10. Ardent Health had a net margin of 3.24% and a return on equity of 19.19%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. As a group, equities analysts anticipate that Ardent Health will post 1.23 earnings per share for the current year.

Hedge Funds Weigh In On Ardent Health

Institutional investors have recently bought and sold shares of the business. CWM LLC raised its stake in Ardent Health by 990.6% in the second quarter. CWM LLC now owns 2,203 shares of the company’s stock worth $30,000 after buying an additional 2,001 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Ardent Health in the 3rd quarter worth $61,000. Quarry LP lifted its stake in shares of Ardent Health by 1,519.4% during the 1st quarter. Quarry LP now owns 5,020 shares of the company’s stock worth $69,000 after purchasing an additional 4,710 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Ardent Health during the 3rd quarter worth $80,000. Finally, New York State Common Retirement Fund grew its stake in Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares during the last quarter.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.